buyWeak

Steven Charles Nelson bought $21k of DRIO

President and CCO at DarioHealth Corp.. 40,000 shares at an average of $0.53, traded Aug 27, 2025, filed Aug 27, 2025.

Conviction score

Value

$21k

40,000 shares

Holdings after

95,000

+73% from before

From 52-week low

+12%

low $8.56, close $9.62

From 52-week high

-69%

high $30.60, as of Aug 27, 2025

Score components

Role
President
+20
Trade size
$21k at market
0
Relative to holdings
Holdings up 73%
+10
Price context
69% below the 52-week high
+8
Cluster
No other insider buying within 14 days
0
Repeat buying
First buy in 90 days
0
Track record
Too few past buys to judge (0 with prices)
0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +37.9%, 3m +24.4%, 6m +11.8%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

DRIOOct 12, 2026 · close 5.42

Since filing Aug 27, 2025: -43.7%SPY +22.0% · excess -65.6%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001104659-25-084035, as filed. Open on EDGAR

Date	Transaction	Shares	Price	Value	Holdings after	Filed
Aug 27, 2025	POpen-market purchase Common Stock	+40,000	$0.53	$21k	95,000	Aug 27, 2025

Related signals

Other insiders at DarioHealth Corp. and this insider’s other filings.

Score	Company	Insider	Value	Holdings	Filed
38Weak	DRIObuy DarioHealth Corp.	Dennis Matheis director	$100k 14,430 shares	+50%	Jul 28, 2026
18Weak	DRIObuy DarioHealth Corp.	Steven Charles Nelson Chief Commercial Officer	$4,546 5,000 shares	+10%	Nov 14, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.